MAR 18, 2015 01:38 PM PDT

Early Biomarkers Found for Parkinson's

WRITTEN BY: Will Hector
The Holy Grail in any progressive disease is to find it early enough to start effective treatment before irreversible damage has occurred. For Parkinson's disease, which afflicts 1.5 million Americans and growing, a new study has brought this goal a little closer.

The study, conducted among more than 54,000 British men and women, identified a slew of symptoms that were more likely to be present in people who years later were diagnosed with Parkinson's. The findings underscore the prevailing view among neurologists that the damage caused by this disease begins long before classic symptoms like tremors, rigidity and an unsteady gait develop and a definite diagnosis can be made.
REM sleep behavior disorder is a prediagnostic symptom of Parkinson's
The study, by Dr. Anette Schrag and fellow neurologists at the University College London, was published in The Lancet in January. As many as five years before a diagnosis of Parkinson's, those who developed it were more likely to have experienced tremor, balance problems, constipation, low blood pressure, dizziness, erectile and urinary dysfunction, fatigue, depression and anxiety.

In addition, Dr. Claire Henchcliffe, director of the Parkinson's Disease and Movement Disorders Institute at Weill Cornell Medical Center, said that REM sleep behavior disorder, characterized by a tendency to act out one's dreams while asleep, is one of the strongest prediagnostic symptoms, along with a lost sense of smell and subtle changes in cognition.

Dr. Melissa J. Nirenberg, a Parkinson's disease specialist at New York University Medical Center, said, "Up to 80 percent of people with the sleep disorder get Parkinson's or a similar neurodegenerative disease."

Although far more study is needed before it will be possible to say that someone has preclinical Parkinson's, people with combinations of the risk factors identified in the study might consider consulting a neurologist who specializes in movement disorders, the experts said.

If a neurological exam suggests the likelihood of Parkinson's, individuals may be eligible to participate in a clinical trial of one or more drugs that may be able to stop or slow progression of the disease by preventing destruction of the brain's dopamine-producing neurons.

By the time patients develop characteristic Parkinson's symptoms, the brain has already lost more than half of its dopamine-producing cells. The goal is to identify those at risk of Parkinson's while their brains are still largely intact, and long before a definitive diagnosis is made.

Luella Adan, for example, was a 40-year-old mother and avid tennis player in 2009 when she first noted what she now believes were early signs of Parkinson's disease.

"I pulled a calf muscle; then I noticed that I limped when I got tired running for a ball," recalled Ms. Adan, a Brooklyn native who now lives in Chicago. "My balance was still fine, but then I pulled a muscle in the other leg. The limp kept getting worse, and I began to feel off-balance. When I closed my eyes, I felt like I would fall backward - I was afraid to take a shower and wash my hair - and I noticed that I couldn't easily move my left leg."

Though always an upbeat person, Ms. Adan said she was getting depressed and having anxiety attacks, and felt so unsteady she hesitated to use the subway. But the first neurologist she consulted could not explain her symptoms.

Finally, in 2012, a second neurologist watched her walk and suggested she get a brain scan that measures dopamine transporter density. It revealed a significant dopamine deficit consistent with Parkinson's.

Bill Reed of Brooklyn was 53 when he learned in 2007 he had Parkinson's. But for three or four years before that, he recalled, he had noticed symptoms like prolonged twitching in his arm and leg muscles, erectile difficulties, a leg that seemed to drag, and an inability to keep up with his wife during their morning walks.

After looking up Parkinson's online, Mr. Reed asked to see a neurologist who confirmed his suspicions.

Both Ms. Adan and Mr. Reed are now being treated medically, doing regular exercises to keep symptoms at a minimum and are generally doing well. But both would have preferred to start treatment much sooner, when the damage in their brains was minimal.

Recognizing that the prediagnostic symptoms associated with Parkinson's are common and quite nonspecific, Dr. Michael S. Okun, medical director of the National Parkinson Foundation, said neurologists are trying to find biomarkers - substances in the blood, saliva or cerebrospinal fluid or imaging characteristics - that would identify those most likely to develop Parkinson's.

Hand in hand with this search is an effort to identify disease-modifying agents that could stop or at least slow progression of Parkinson's in people at high risk. Todd Sherer, chief executive of the Michael J. Fox Foundation, noted that two recent prospects - creatine and coenzyme Q10 - did not hold up in clinical trials. But a few other substances - a vaccine against a protein called alpha-synuclein, a blood pressure drugcalled isradipine, and inosine, a supplement that raises urate levels, are showing promise in clinical trials now underway.

"Right now we have no treatment to prevent or slow Parkinson's," Dr. Nirenberg said. "But by simultaneously searching for biomarkers, the minute we find something that works, we want to be able to identify everyone who could use it."

Dr. Henchcliffe suggested that people with symptoms predictive of Parkinson's, as well as the relative few who are genetically at risk, adopt healthful exercise and dietary habits that may forestall the disease.

"All forms of exercise seem to be good - dance, aerobics, stretching, whatever appeals to you," she said. "With respect to diet, a Mediterranean-style diet" - rich in fresh fruits and vegetables, whole grains, fish and olive oil - "is most closely associated with a reduced risk of developing Parkinson's."

"There have also been some odd papers suggesting that certain foods, like red peppers and the flavonoids in apples, are protective," Dr. Henchcliffe said, adding that careful studies are needed to determine if any specific foods or dietary substances are truly beneficial.

Source: New York Times
About the Author
  • Will Hector practices psychotherapy at Heart in Balance Counseling Center in Oakland, California. He has substantial training in Attachment Theory, Hakomi Body-Centered Psychotherapy, Psycho-Physical Therapy, and Formative Psychology. To learn more about his practice, click here:
You May Also Like
SEP 15, 2019
Genetics & Genomics
SEP 15, 2019
Bipolar Disorder & Schizophrenia Linked to Epigenetic Hotspot
Researchers may have found a way to develop better therapeutics and test for the diseases, which are difficult to diagnose and treat....
SEP 15, 2019
Plants & Animals
SEP 15, 2019
Kakapo Parrot Chick Undergoes Life-Saving Brain Surgery
The kakapo parrot (Strigops habroptilus), recognized by the International Union for Conservation of Nature (IUCN) as a critically-endangered species on the...
SEP 15, 2019
Cannabis Sciences
SEP 15, 2019
Growing up high: new insights into how cannabis changes the adolescent brain
During adolescence, important cognitive functions develop. Adolescence is a highly sensitive period for brain development as it represents a time when regions of the frontal cortex in charge...
SEP 15, 2019
Drug Discovery
SEP 15, 2019
Why Drugs that Work on Mice Don't Work on Humans
Mice are used as the frontline for drug testing for brain disorders. Why? Their brains are supposed to have much of the same functioning as ours. Moreover,...
SEP 15, 2019
Chemistry & Physics
SEP 15, 2019
Scientists Developed Magnetic Nanoparticles that can Remotely Modulate Neural Circuits
Currently, neuroscience researchers rely heavily on invasive procedures to stimulate and study the neural activity of animals. A team of MIT scientists has...
SEP 15, 2019
SEP 15, 2019
Neuroscientists create a stunning digital map of 1,000 neurons
Two years ago, Dr. Jayaram Chandrashekar and his colleagues at the Howard Hughes Medical Institute's Janelia Research Campus sought out to map the mouse brain as intricately as possible. Now,...
Loading Comments...